Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 660,566 | 591,643 | 509,728 | 484,329 | 444,448 |
| Cost of Goods | 370,466 | 347,039 | 321,832 | 297,269 | 258,555 |
| Gross Profit | 290,100 | 244,604 | 187,896 | 187,060 | 185,893 |
| Operating Expenses | 382,672 | 352,379 | 346,351 | 306,083 | 200,440 |
| Operating Income | -92,106 | -107,736 | -157,623 | -118,754 | -13,992 |
| Interest Expense | 6,617 | 6,907 | 7,581 | 8,220 | 7,019 |
| Other Income | 18,048 | 17,546 | 5,862 | 111,899 | 6,955 |
| Pre-tax Income | -80,675 | -97,097 | -159,342 | -15,075 | -14,056 |
| Income Tax | -1,949 | -9,129 | -15,092 | -6,728 | -18,228 |
| Net Income Continuous | -78,726 | -87,968 | -144,250 | -8,347 | 4,172 |
| Net Income | $-78,726 | $-87,968 | $-144,250 | $-8,347 | $4,172 |
| EPS Basic Total Ops | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 |
| EPS Basic Continuous Ops | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 |
| EPS Diluted Total Ops | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 |
| EPS Diluted Continuous Ops | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.31 | -0.76 | -0.27 | 0.07 |
| EBITDA(a) | $-16,645 | $-32,277 | $-85,354 | $-62,661 | $26,252 |